TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30650289

Group type: EXPERIMENTAL
Intervention: Shaoyao Gancao Decoction (SGD)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Olanzapine Tablet (OT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Both groups (SGD and OT)
Number of subjects: 120
Study: 24940825

Group type: EXPERIMENTAL
Intervention: InsuPad (modulation device)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (without device)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study: 23141789

Group type: EXPERIMENTAL
Intervention: Thought Field Therapy (TFT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Waiting list (control)
Number of subjects: 45
Study: 19850944

Group type: EXPERIMENTAL
Intervention: AA genotype of rs1042717 in patients with septic shock
Number of subjects: 1205
Study: 18173143

Group type: EXPERIMENTAL
Intervention: Aike Decoction for smoothing Gan‐qi
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Bazhengsan Decoction for clearing heat and removing dampness
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Qianliexianyan Decoction for promoting blood circulation to remove stasis
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo (Group D)
Number of subjects: 218
Study: 16274999

Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/die)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal patients (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Coronary patients (baseline)
Number of subjects: 40
Study: 12135285

Group type: EXPERIMENTAL
Intervention: WR279396
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 9895383

Group type: EXPERIMENTAL
Intervention: Botulinum toxin
Number of subjects: 42

Group type: COMPARATOR
Intervention: Pneumatic dilatation
Number of subjects: 42
Study: 7845026

Group type: EXPERIMENTAL
Intervention: GM-CSF (E. coli, 250 micrograms/m2/day, s.c.)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 8
Study: 2220572

Group type: EXPERIMENTAL
Intervention: Verapamil (360 mg/day)
Number of subjects: 1775

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1775
Study: 883329

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy after simple mastectomy
Number of subjects: 2268

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy in patients with positive nodes
Number of subjects: 2268

Group type: COMPARATOR
Intervention: Simple mastectomy followed by watch policy
Number of subjects: 2268
Study: 30813212

Group type: EXPERIMENTAL
Intervention: High-fidelity simulator (Group 3D)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional simulator (Group C)
Number of subjects: 52
Study: 28543041

Group type: EXPERIMENTAL
Intervention: CI-PPV group (cardiac index and pulse pressure variation monitoring)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Control group (mean arterial pressure-guided therapy only)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: CI-PPV group
Number of subjects: 244

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 244
Study: 25657106

Group type: EXPERIMENTAL
Intervention: Occupational therapy intervention (3 month programme)
Number of subjects: 1042

Group type: COMPARATOR
Intervention: Standard care (control arm)
Number of subjects: 1042

Group type: EXPERIMENTAL
Intervention: Occupational therapy intervention
Number of subjects: 1042
Study: 24521775

Group type: EXPERIMENTAL
Intervention: MMF/pred
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: MMF/CsA
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: MMF/CsA/pred
Number of subjects: 212

Group type: COMPARATOR
Intervention: CNI withdrawal
Number of subjects: 212

Group type: COMPARATOR
Intervention: No rejection
Number of subjects: 212
Study: 21907349

Group type: EXPERIMENTAL
Intervention: Theophylline plus 0.5 L/min of room air via nasal prongs
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo plus 0.5 L/min with CO(2) (about 1% inhaled) by nasal prongs
Number of subjects: 87

Group type: COMPARATOR
Intervention: CO(2) group
Number of subjects: 87
Study: 19506333

Group type: EXPERIMENTAL
Intervention: pHGF treatment
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 49
Study: 17443476

Group type: EXPERIMENTAL
Intervention: Cotrimoxazole prophylaxis
Number of subjects: 534

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Cotrimoxazole prophylaxis after trial closure
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Combined groups during ART availability
Number of subjects: 534
Study: 15138753

Group type: EXPERIMENTAL
Intervention: Piribedil (50 mg daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15167213

Group type: EXPERIMENTAL
Intervention: Reduction in red meat intake
Number of subjects: 1905

Group type: EXPERIMENTAL
Intervention: High intake of fish
Number of subjects: 1905
Study: 12575393

Group type: EXPERIMENTAL
Intervention: Kuhuang Shenmai injection (KHSM) combined with Astragalus decoction (AD)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Ribarvirin and ganlixin injection
Number of subjects: 186
Study: 9627948

Group type: EXPERIMENTAL
Intervention: Intraarticular methotrexate (MTX) therapy (10 mg injections every 3 to 7 days)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Intraarticular triamcinolone hexacetonide (TC) therapy (40 mg single injection)
Number of subjects: 5
Study: 8185271

Group type: EXPERIMENTAL
Intervention: Paracervical block with lidocaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: No anaesthesia
Number of subjects: 40
Study: 2895909

Group type: EXPERIMENTAL
Intervention: Terfenadine (60 mg)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Terfenadine
Number of subjects: 250
Study: 30274305

Group type: EXPERIMENTAL
Intervention: Incobotulinumtoxin A (IncoA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 24
Study: 28012910

Group type: EXPERIMENTAL
Intervention: Arm crank exercise (15 x 2 minutes bouts with 2 minutes rest)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Arm crank exercise
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control
Number of subjects: 11
Study: 26307566

Group type: EXPERIMENTAL
Intervention: Amino acid solution (TrophAmine®)
Number of subjects: 430

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 430
Study: 23223825

Group type: EXPERIMENTAL
Intervention: FDG-PET
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Histopathology
Number of subjects: 98
Study: 21620748

Group type: EXPERIMENTAL
Intervention: Nitisinone
Number of subjects: 40
Study: 17487227

Group type: EXPERIMENTAL
Intervention: CX516 900 mg three times daily
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 16492602

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rHuEPO) injections
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (sodium chloride solution)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (no injection)
Number of subjects: 6
Study: 12808541

Group type: EXPERIMENTAL
Intervention: Indoor 6-minute walk test (6MWT)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Outdoor 6-minute walk test (6MWT)
Number of subjects: 18
Study: 11127459

Group type: EXPERIMENTAL
Intervention: Oral glucose loading (75 g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Oral glucose loading (75 g) + vitamins C (2 g) and E (800 IU)
Number of subjects: 10
Study: 8822657

Group type: EXPERIMENTAL
Intervention: Warm tub bath during labor
Number of subjects: 1385

Group type: COMPARATOR
Intervention: Reference group (no bath)
Number of subjects: 1385
Study: 1396832

Group type: EXPERIMENTAL
Intervention: Enalapril (n = 11)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (n = 11)
Number of subjects: 22
Study: 3925290

Group type: EXPERIMENTAL
Intervention: Unmodified niacin
Number of subjects: 71

Group type: COMPARATOR
Intervention: Time-release niacin
Number of subjects: 71
Study: 30724580

Group type: EXPERIMENTAL
Intervention: Quality of life measured using anamnestic comparative self-assessment (range -5 to +5)
Number of subjects: 171
Study: 31242671

Group type: EXPERIMENTAL
Intervention: Adherence to Nordic Nutrition Recommendations (NNR)
Number of subjects: 5000

Group type: EXPERIMENTAL
Intervention: Fruits and vegetable intakes
Number of subjects: 5000

Group type: EXPERIMENTAL
Intervention: Dietary fiber intake for women
Number of subjects: 5000
Study: 30400111

Group type: EXPERIMENTAL
Intervention: Somatosensory discrimination retraining
Number of subjects: 80
Study: 26919838

Group type: EXPERIMENTAL
Intervention: Nursing home patient
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Elderly trained patient actor
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Virtual patient
Number of subjects: 62

Group type: COMPARATOR
Intervention: All groups (Nursing home, Elderly actor, Virtual)
Number of subjects: 62
Study: 23180147

Group type: EXPERIMENTAL
Intervention: Fibrin sealant group (FSG)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Lichtenstein group (LTG)
Number of subjects: 102
Study: 22883307

Group type: EXPERIMENTAL
Intervention: Hyperinvasive approach (mechanical chest compression device, prehospital intraarrest cooling, extracorporeal life support, early invasive assessment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study: 19250005

Group type: EXPERIMENTAL
Intervention: Interactive Guided Imagery (IGI)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 12
Study: 17768460

Group type: EXPERIMENTAL
Intervention: Esmolol infusion of 50‐250 ug.kg‐1.min‐1 after a bolus of 0.5 mgxkg‐1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion of 0.2‐0.5 ugxkg‐1xmin‐1
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups (Esmolol and Remifentanil)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Remifentanil
Number of subjects: 40
Study: 16163242

Group type: EXPERIMENTAL
Intervention: New cytotoxic agents and novel targeted therapies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Targeted therapeutics
Number of subjects: 0
Study: 12439769

Group type: EXPERIMENTAL
Intervention: Salbutamol (Sal, 6 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Caffeine (Caf, 250 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (Pla)
Number of subjects: 8
Study: 10416555

Group type: EXPERIMENTAL
Intervention: Follicular phase exercise (N = 5)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Luteal phase exercise (N = 4)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (N = 6, 3 low volume exercise, 3 sedentary)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Comparison of menstrual cycle disruption
Number of subjects: 9
Study: 8645964

Group type: EXPERIMENTAL
Intervention: Intranasal midazolam (0.34 mg (kg body weight)‐1)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Intravenous midazolam (0.31 mg (kg body weight)‐1)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Intranasal midazolam
Number of subjects: 63

Group type: COMPARATOR
Intervention: Intravenous midazolam
Number of subjects: 63
Study: 2188189

Group type: EXPERIMENTAL
Intervention: Increase in mean myopia from -1.43 to -3.06 D
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Increase in myopia
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Higher spherical equivalent at end of study
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Higher ASFE at end of study
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Wearing of spectacles
Number of subjects: 238
Study: 7324823

Group type: EXPERIMENTAL
Intervention: Rectal diazepam (0.75 mg kg‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of diazepam premedications and a small dose of lytic cocktail (pethidine, promethazine, chlorpromazine) given i.m. during anaesthesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lytic cocktail (control)
Number of subjects: 0
Study: 6387616

Group type: EXPERIMENTAL
Intervention: Polymorphonuclear leukocyte transfusions every 12 hours for a total of five transfusions (15 mL/kg per transfusion)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Supportive care alone
Number of subjects: 23
Study: 29502081

Group type: EXPERIMENTAL
Intervention: Exercise Referral Scheme (ERS) linked to community resources and social support for 12 weeks
Number of subjects: 422

Group type: COMPARATOR
Intervention: Usual care from primary care practice
Number of subjects: 422
Study: 27416494

Group type: EXPERIMENTAL
Intervention: Men with OSA
Number of subjects: 796

Group type: EXPERIMENTAL
Intervention: Women with OSA
Number of subjects: 796
Study: 24885816

Group type: EXPERIMENTAL
Intervention: Perilla frutescens extract
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Perilla frutescens extract (women subgroup)
Number of subjects: 50
Study: 23171244

Group type: EXPERIMENTAL
Intervention: 38% SDF treatment
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: ART sealant treatment
Number of subjects: 704

Group type: COMPARATOR
Intervention: SDF treatment
Number of subjects: 704

Group type: COMPARATOR
Intervention: Non-treated children
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Sealant-treated children
Number of subjects: 704
Study: 20237046

Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate (500 μg via spacer device)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 120
Study: 18697630

Group type: EXPERIMENTAL
Intervention: Normal glucose tolerance (NGT) at baseline
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Pre-diabetic at baseline
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Abdominal obesity
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Indian Diabetes Risk Score (IDRS)
Number of subjects: 476
Study: 15080014

Group type: EXPERIMENTAL
Intervention: Nicardipine (starting dose 3 micrograms/kg per min)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nitroprusside (starting dose 1 microgram/kg per min)
Number of subjects: 40
Study: 11480466

Group type: EXPERIMENTAL
Intervention: Active Back School
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control
Number of subjects: 81
Study: 9444665

Group type: EXPERIMENTAL
Intervention: Alpha-trinositol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (sodium chloride)
Number of subjects: 0
Study: 7936677

Group type: EXPERIMENTAL
Intervention: Electrocautery division of the thyroid isthmus during tracheostomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Older techniques for division of the thyroid isthmus
Number of subjects: 0
Study: 3281704

Group type: EXPERIMENTAL
Intervention: HDM solution applied daily to mildly eczematous or clinically uninvolved skin for 5 days.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HDM solution applied to normal, unabraded skin of prick test positive subjects without a history of dermatitis.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle or antigen solution applied to subjects negative on prick testing.
Number of subjects: 0
Study: 29926910

Group type: EXPERIMENTAL
Intervention: Prompting home-school cultural value conflict
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Prompting family obligation (without mention of conflict)
Number of subjects: 161
Study: 27687449

Group type: EXPERIMENTAL
Intervention: BARRIER EasyWarm blanket
Number of subjects: 246

Group type: COMPARATOR
Intervention: Passive thermal insulation (control group)
Number of subjects: 246
Study: 24489072

Group type: EXPERIMENTAL
Intervention: Non-sustained or diverted (NSD) episodes within 24 hours before inappropriate shock
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: NSD episode within 14 minutes before shock
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: NSD episodes in ALTITUDE-REDUCES Study
Number of subjects: 185
Study: 23034957

Group type: EXPERIMENTAL
Intervention: Low-fat diet (20% from energy)
Number of subjects: 591

Group type: COMPARATOR
Intervention: High-fat diet (40% from energy)
Number of subjects: 591
Study: 20550022

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) treatment for 6 to 9 months
Number of subjects: 32

Group type: COMPARATOR
Intervention: Hyperoxia
Number of subjects: 32

Group type: COMPARATOR
Intervention: Hypercapnia (8% CO2)
Number of subjects: 32
Study: 17394129

Group type: EXPERIMENTAL
Intervention: 1 hour per week liaison input per home for 20 weeks to deliver a personalised intervention package
Number of subjects: 238

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: 1 hour per week liaison input per home for 20 weeks
Number of subjects: 238
Study: 15788475

Group type: EXPERIMENTAL
Intervention: Medihoney (honey)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Mupirocin (control)
Number of subjects: 101
Study: 12071273

Group type: EXPERIMENTAL
Intervention: WALC intervention
Number of subjects: 17

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 17
Study: 9615962

Group type: EXPERIMENTAL
Intervention: Artificial tear treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Physiological saline (control group)
Number of subjects: 60
Study: 7805977

Group type: EXPERIMENTAL
Intervention: Nipple stimulation (15 min)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Syntometrine injection
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (no action)
Number of subjects: 14
Study: 2505960

Group type: EXPERIMENTAL
Intervention: Flumazenil (30 mg oral dose)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Flumazenil (2 mg intravenous dose)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (healthy volunteers)
Number of subjects: 16
Study: 1094320

Group type: EXPERIMENTAL
Intervention: Fludrocortisone, 0.1 mg twice daily
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 30742815

Group type: EXPERIMENTAL
Intervention: Low variable suction (−5 cm H2O)
Number of subjects: 106

Group type: COMPARATOR
Intervention: High variable suction (−20 cm H2O)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 106
Study: 28270204

Group type: EXPERIMENTAL
Intervention: Flipped Classroom
Number of subjects: 181

Group type: COMPARATOR
Intervention: Lecture‐Based Learning (LBL)
Number of subjects: 181
Study: 27399127

Group type: EXPERIMENTAL
Intervention: Intradialytic aerobic cycling exercise
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 24126064

Group type: EXPERIMENTAL
Intervention: Teriflunomide 14 mg
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Teriflunomide 7 mg
Number of subjects: 324

Group type: COMPARATOR
Intervention: IFNβ‐1a
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Teriflunomide
Number of subjects: 324
Study: 22495146

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin matrix (PRFM) applied at the tendon-bone interface
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard repair with no PRFM (Control)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin matrix (PRFM)
Number of subjects: 79
Study: 19329389

Group type: EXPERIMENTAL
Intervention: Lentil-based high protein diet (LenP)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Animal-based high protein diet (AP)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Low protein diet (LP)
Number of subjects: 31
Study: 17488411

Group type: EXPERIMENTAL
Intervention: GIK infusion (n = 14)
Number of subjects: 31

Group type: COMPARATOR
Intervention: No-GIK (n = 17)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both groups (GIK and No-GIK)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: GIK infusion
Number of subjects: 31
Study: 15204277

Group type: EXPERIMENTAL
Intervention: Non-verbal auditory alarms
Number of subjects: 0
Study: 12228778

Group type: EXPERIMENTAL
Intervention: Type I antiarrhythmic agents (secondary prevention after myocardial infarction)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillators
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alternative therapy (most often amiodarone)
Number of subjects: 0
Study: 10100392

Group type: EXPERIMENTAL
Intervention: Heroin addicts
Number of subjects: 116

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 116
Study: 8578181

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole daily for 6 months
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: 10 mg omeprazole daily for 6 months
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: 40 mg omeprazole daily for 4-8 weeks
Number of subjects: 220
Study: 2189929

Group type: EXPERIMENTAL
Intervention: Five-drug antiemetic regimen (metoclopramide, dexamethasone, diazepam, diphenhydramine, thiethylperazine)
Number of subjects: 13

Group type: COMPARATOR
Intervention: High-dose metoclopramide
Number of subjects: 13
Study: 707580

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Promethazine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dexamethasone and Promethazine together
Number of subjects: 20

Group type: COMPARATOR
Intervention: Neither agent (control group)
Number of subjects: 20
Study: 30732514

Group type: EXPERIMENTAL
Intervention: Loudness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pitch
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simultaneous effects of loudness and pitch
Number of subjects: 0
Study: 31238061

Group type: EXPERIMENTAL
Intervention: Exercise videogames (EVGs) for 12 weeks
Number of subjects: 84

Group type: COMPARATOR
Intervention: Standard exercise (e.g., treadmill, cycling)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Exercise videogames (EVGs)
Number of subjects: 84